Angle PLC
LSE:AGL

Watchlist Manager
Angle PLC Logo
Angle PLC
LSE:AGL
Watchlist
Price: 9.6 GBX 2.67% Market Closed
Market Cap: 31m GBX
Have any thoughts about
Angle PLC?
Write Note

Angle PLC
Investor Relations

ANGLE Plc operates as a holding company, through its subsidiaries engages in providing products in cancer diagnostics and foetal health. The company is headquartered in Guildford, Surrey and currently employs 102 full-time employees. The company went IPO on 2004-03-17. The Company’s lead product is the Parsortix cell separation system, which captures very rare cells from the blood. This includes circulating tumor cells (CTCs) in cancer patient blood even when there is less than one CTC in one billion healthy cells. The Parsortix cell separation system uses a microfluidic technology in the form of a one-time use cassette to capture and then harvest circulating tumor cells (CTCs) from blood. The cassette captures CTCs based on their less deformable nature and larger size compared to other blood components. The Company’s translational research includes ovarian cancer, breast cancer, prostate cancer and small cell lung cancer.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Andrew David William Newland ACA, Meng
Founder, CEO & Executive Director
No Bio Available
Mr. Ian Francis Griffiths ACA, BA
CFO, Finance Director, Company Secretary & Executive Director
No Bio Available

Contacts

Address
SURREY
Guildford
The Surrey Research Park, 10 Nugent Road
Contacts
+441483343434.0
www.angleplc.com